Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

RIGLRIGL
Showing 4 of 10 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in RIGEL PHARMACEUTICALS INC

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 167,342 shares of RIGL (RIGEL PHARMACEUTICALS INC), worth $4.5M as of 2026-Q1. The position was decreased (-59.5% shares). RIGL represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$4.5M

Current Shares

167,342

Total Value Change

+$4.1M

Total Shares Change

+145,359

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
167,342
-59.5%
$4.5M0.0%$33.02
0
2025-Q4
Increased
413,659
+122.0%
$17.7M0.0%$42.83
46
2025-Q3
Increased
186,326
+747.6%
$5.3M0.0%$28.75
44
2025-Q2
New
21,983
-
$411,7420.0%$19.48
33

Other major holders of RIGL: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used